Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)
1,589.00
0.00 (0.00%)
At close: Nov 14, 2025
CBSE:PRO Revenue
Societe de Promotion Pharmaceutique du Maghreb had revenue of 464.22M MAD in the half year ending June 30, 2025, with 27.27% growth. This brings the company's revenue in the last twelve months to 928.99M, up 11.80% year-over-year. In the year 2024, Societe de Promotion Pharmaceutique du Maghreb had annual revenue of 898.71M with 11.57% growth.
Revenue (ttm)
928.99M
Revenue Growth
+11.80%
P/S Ratio
1.71
Revenue / Employee
2.71M
Employees
343
Market Cap
1.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 898.71M | 93.20M | 11.57% |
| Dec 31, 2023 | 805.52M | 100.88M | 14.32% |
| Dec 31, 2022 | 704.64M | 74.15M | 11.76% |
| Dec 31, 2021 | 630.49M | 57.30M | 10.00% |
| Dec 31, 2020 | 573.20M | 50.75M | 9.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Itissalat Al-Maghrib (IAM) | 36.48B |
| Attijariwafa bank | 32.12B |
| Banque Centrale Populaire | 20.49B |
| Bank of Africa | 16.62B |
| TAQA Morocco | 10.61B |
| Travaux Généraux de Construction de Casablanca S.A | 9.13B |
| Managem | 8.87B |
| LafargeHolcim Maroc | 8.62B |